Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report)’s stock price was down 5.4% during trading on Friday. The company traded as low as $9.5950 and last traded at $9.73. 101,440 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 293,445 shares. The stock had previously closed at $10.2832.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on the stock. Citigroup reiterated a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three investment analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.
Get Our Latest Stock Report on CURLF
Curaleaf Trading Down 3.8%
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.25. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. The firm had revenue of $340.10 million during the quarter, compared to analysts’ expectations of $332.00 million. On average, research analysts predict that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current year.
Curaleaf Company Profile
Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.
Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.
Recommended Stories
- Five stocks we like better than Curaleaf
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
